These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 1036803)

  • 1. Molecular size distribution of fibrinogen derivatives formed in vitro and in vivo: a chromatographic study.
    Donati MB; Verhaeghe R; Culasso DE; Vermylen J
    Thromb Haemost; 1976 Aug; 36(1):14-26. PubMed ID: 1036803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapid chromatographic method for quantitation of high molecular weight fibrinogen derivatives in plasma.
    Musumeci V; Culasso D; Boni P
    Thromb Haemost; 1978 Jun; 39(3):555-63. PubMed ID: 705685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: Streptokinase degradation during the formation of a plasmin(ogen)-fibrinogen complex with activator activity.
    Chesterman CN; Allington MJ; Cederholm-Williams SA; Sharp AA
    Br J Haematol; 1974 Jun; 27(2):365. PubMed ID: 4846464
    [No Abstract]   [Full Text] [Related]  

  • 4. Soluble fibrin complexes and fibrinogen heterogeneity in diabetes mellitus.
    Tsianos EB; Stathakis NE
    Thromb Haemost; 1980 Dec; 44(3):130-4. PubMed ID: 6162208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of proteins adsorbed from human plasma to glass bead columns: plasmin-induced degradation of adsorbed fibrinogen.
    Brash JL; Thibodeau JA
    J Biomed Mater Res; 1986; 20(9):1263-75. PubMed ID: 2946694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in the content of fibrinogen and its high-molecular derivatives as affected by the physical training of ischemic heart disease patients].
    Dudaev VA; Diukov IV; Borodkin VV
    Ter Arkh; 1986; 58(12):62-7. PubMed ID: 3824217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of soluble very high molecular weight fibrinogen complexes in hypercoagulable states. An in vitro and in vivo study on their features.
    Neri Serneri GG; Gensini GF; Abbate R; Favilla S
    Thromb Haemost; 1980 Feb; 42(5):1561-73. PubMed ID: 6768154
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrin-I degradation products with a molecular weight higher than that of fibrinogen. Identification and characterization of in vitro products from human plasma.
    von Hugo R; Graeff H
    Thromb Diath Haemorrh; 1973 Feb; 29(1):122-9. PubMed ID: 4708590
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrin formed in plasma is composed of fibers more massive than those formed from purified fibrinogen.
    Carr ME
    Thromb Haemost; 1988 Jun; 59(3):535-9. PubMed ID: 3187937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure.
    Switzer ME; McKee PA
    J Clin Invest; 1976 Apr; 57(4):925-37. PubMed ID: 1084890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the purification of antihemophilic factor (factor VIII). II. Separation of partially purified antihemophilic factor by gel filtration of plasma.
    Ratnoff OD; Kass L; Lang PD
    J Clin Invest; 1969 May; 48(5):957-62. PubMed ID: 5780204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo.
    Plow E; Edgington TS
    J Clin Invest; 1973 Feb; 52(2):273-82. PubMed ID: 4119160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inactivation of hemostatic factors by hematin.
    Green D; Reynolds N; Klein J; Kohl H; Ts'ao CH
    J Lab Clin Med; 1983 Sep; 102(3):361-9. PubMed ID: 6411843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of fibrinopeptide A in human blood.
    Nossel HL; Yudelman I; Canfield RE; Butler VP; Spanondis K; Wilner GD; Qureshi GD
    J Clin Invest; 1974 Jul; 54(1):43-53. PubMed ID: 4600045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Estimation of soluble fibrin monomer complexes for evaluation of hypercoagulability during pregnancy and delivery (author's transl)].
    Hafter R; Schneebauer T; Tafel K; Ernst E; Graeff H
    Geburtshilfe Frauenheilkd; 1975 Jul; 35(7):518-25. PubMed ID: 1213264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on fibrinogen heterogeneity in disseminated intravascular coagulation].
    Yamauchi M
    Hokkaido Igaku Zasshi; 1982 Jul; 57(4):425-36. PubMed ID: 7173813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fibrinogen-fibrin derivatives during difibrase therapy. Detection and course observations of high-molecular and low-molecular derivatives using agarose gel filtration].
    Asbeck F; Lechler E; van de Loo J
    Verh Dtsch Ges Inn Med; 1974; 80():1466-70. PubMed ID: 4454459
    [No Abstract]   [Full Text] [Related]  

  • 20. Soluble fibrin monomer complexes demonstrated by agarose gel filtration and by adsorption on insolubilized fibrinogen: a comparative study.
    von Hugo R; Stemberger A; Graeff H
    Thromb Diath Haemorrh; 1975 Sep; 34(1):216-22. PubMed ID: 1188711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.